Drug Database
Back to search

Switzerland· 67632002

Aklief

A trifarotene product containing trifarotenum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC D10AD06

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAkliefATCD10AD06REGISTER NO.67632002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trifarotenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trifarotene is registered in 15 of 19 countries.

Countries holding a registration under ATC D10AD06 (trifarotene), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search trifarotene products by name

Trifarotene · ATC D10AD06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
trifarotenum
Manufacturer
—
Country
Switzerland (CH)
ATC code
D10AD06
ATC class
Trifarotene
Defined daily dose
50 mcg, T
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680676320027
    Disp 75 g
    CHF 43.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for trifarotene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check trifarotene against other medicinesHow interaction checks work

Trifarotene · interactions on record

9 records

  • 1 severe
  • 8 moderate

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • Benzoyl peroxideD10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trifarotene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trifarotene products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Belgium · Aklief
  • Bulgaria · Аклиеф
  • Cyprus · Selgamis
  • Czechia · Aklief
  • Germany · Selgamis
  • Denmark · Aklief
  • Estonia · Aklief
  • Spain · Aklief
  • Finland · Aklief
  • France · Aklief
  • United Kingdom (Northern Ireland) · Aklief
  • Greece · Selgamis
  • Croatia · Aklief
  • Hungary · Aklief
  • Ireland · Aklief
  • Iceland · Aklief
  • Italy · Selgamis
  • Lithuania · Aklief
  • Luxembourg · Aklief
  • Latvia · Aklief
  • Malta · Aklief
  • Netherlands · Aklief
  • Norway · Aklief
  • Poland · Aklief
  • Portugal · Aklief
  • Romania · Aklief
  • Sweden · Aklief
  • Slovakia · Aklief

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2de66afb-51f0-4fb7-b975-bfeae0c2ce64
GET /v1/drugs/2de66afb-51f0-4fb7-b975-bfeae0c2ce64?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "trifarotenum 50 mcg",
  "valid_from": "2021-04-01",
  "limitations": null,
  "galenic_form": "Creme 50 mcg/g",
  "therapeutic_area": null,
  "sl_inclusion_date": "2021-04-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about trifarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console